Digma Medical

Noninvasive Procedure for Diabetes Treatment

Health Tech & Life Sciences
Active
Series B Giv'at Shmuel, Israel Founded 2013
Last updated 2026-06-18
Total raised
$2.4M
Last: Undisclosed Round 2022-05
Stage
Series B
Founded
2013
Headcount
14
HQ
Giv'at Shmuel, Israel
Sector
Health Tech & Life Sciences

About

Digma aims to harness the power of the duodenum to empower patients and physicians with safe, simple and effective new therapies for type 2 diabetes that enable them to live longer, healthier and happier lives.

The company is developing a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body’s natural ability to control blood glucose levels. The treatment targets the duodenal submucosa which is central to nutrient sensing and metabolic signaling. The product consists of a console and a single-use catheter that is compatible with the working channel of standard gastrointestinal endoscopes. The EGM procedure is being developed so that it can be performed in a standard GI endoscopy suite without requiring additional imaging equipment. The goal is to provide patients with durable improvement in glycemic control with minimal side effects and without requiring additional daily medical therapy.

Funding history · 4 rounds · $2.4M total

2022-05
Undisclosed Round $360K
2018-05
Undisclosed Round Undisclosed
2016-12
B Round Undisclosed
2015-04
A Round $2.0M

Q&A

What is Digma Medical's primary focus?
Digma Medical is developing a noninvasive procedure for Type 2 Diabetes treatment, specifically a minimally invasive therapy called Endoscopic Glycemic Management (EGM) to restore the body’s natural ability to control blood glucose levels.
When was Digma Medical founded?
Digma Medical was founded in January 2013.
What is Digma Medical's current employee count?
Digma Medical has 14 employees, which falls into the 11-50 employee bucket.
How much funding has Digma Medical raised in total?
Digma Medical has raised a total of $2,360,000.
Which investors participated in Digma Medical's Series A round?
Accelmed was the lead investor in Digma Medical's Series A round in April 2015.
Who are the co-founders of Digma Medical?
The co-founders of Digma Medical are Irit Yaniv and Ilan Ben-Oren.
What is the product stage of Digma Medical's therapy?
Digma Medical's product is currently in the clinical trial stage.

Team · 2

Founder · Co-founder
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

bioconvergenceminimally-invasivemetabolic-diseasemedical-technologiesdiabetesmedical-devicesgastroenterologyhospitalsdoctorshealthcare-providersendoscopycatheterstreatmentstype-2-diabetes
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitedigmamedical.com
LinkedInlinkedin.com/company/6142779

Identifiers & details

Founded2013-1
Employees (exact)14

Radar intelligence

Patents

EPO6

Web history (Wayback)

Domaindigmamedical.com

Certificate / subdomain footprint

Subdomains2